These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3488716)

  • 1. Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies.
    Ebringer A; Ghuloom M
    Ann Rheum Dis; 1986 Aug; 45(8):703-4. PubMed ID: 3488716
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity of anti-Klebsiella K43 antiserum and lymphocytes from HLA-B27-positive patients with ankylosing spondylitis.
    Struthers GR
    Lancet; 1985 Mar; 1(8431):764. PubMed ID: 2858037
    [No Abstract]   [Full Text] [Related]  

  • 3. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity?
    Geczy AF; Prendergast JK; McGuigan LE; Upfold LI; Sullivan JS
    Lancet; 1985 May; 1(8438):1169. PubMed ID: 2860379
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
    J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella.
    Ebringer A; Baines M; Ptaszynska T
    Immunol Rev; 1985 Aug; 86():101-16. PubMed ID: 2412951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

  • 10. Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis.
    Ebringer A; Cox NL; Abuljadayel I; Ghuloom M; Khalafpour S; Ptaszynska T; Shodjai-Moradi F; Wilson C
    Br J Rheumatol; 1988; 27 Suppl 2():72-85. PubMed ID: 3042077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27: speculations on the nature of its involvement in ankylosing spondylitis.
    Upfold LI; Sullivan JS; Prendergast JK; Geczy AF
    Prog Allergy; 1985; 36():177-89. PubMed ID: 3881781
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
    Baines M; Ebringer A; Avakian H; Samuel D; James DC
    Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enigma of the Klebsiella connection and ankylosing spondylitis: a commentary.
    Prendergast JK; Sullivan JS; Geczy AF; Upfold LI; Edmonds JP; Bashir HV
    Hum Immunol; 1984 Mar; 9(3):131-6. PubMed ID: 6365855
    [No Abstract]   [Full Text] [Related]  

  • 14. Regarding the ankylosing spondylitis/Klebsiella/HLA-B27 problem.
    Terasaki PI; Yu DT
    Arthritis Rheum; 1987 Mar; 30(3):353-4. PubMed ID: 3551967
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to the editorial by Terasaki and Yu on the ankylosing spondylitis/Klebsiella/HLA-B27 problem.
    Geczy AF; Sullivan JS; McGuigan LE
    Arthritis Rheum; 1987 Jun; 30(6):714-5. PubMed ID: 3300661
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 17. Ankylosing spondylitis, HLA-B27, and klebsiella.
    Geczy AF
    Ann Rheum Dis; 1986 Mar; 45(3):261-2. PubMed ID: 3485411
    [No Abstract]   [Full Text] [Related]  

  • 18. Further observations on Klebsiella molecular cross-reactivity in HLA-B27 positive persons.
    Trull AK; Panayi GS
    J Rheumatol; 1985 Oct; 12(5):1024. PubMed ID: 3910831
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis.
    Upfold LI; Sullivan JS; Geczy AF
    Hum Immunol; 1986 Nov; 17(3):224-38. PubMed ID: 3539895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of isolates of Klebsiella pneumoniae which cross-react with HLA-B27-associated cell-surface structure on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Yap J
    J Rheumatol; 1982; 9(1):97-100. PubMed ID: 7045364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.